Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meera R Chappidi

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Urology|July 28, 2016
Quantifying Nonindex Hospital Readmissions and Care Fragmentation after Major Urological Oncology Surgeries in a Nationally Representative SampleMeera R Chappidi, Max Kates, C J Stimson, et al.
The Journal of Urology|August 23, 2016
Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of CareMeera R Chappidi, Max Kates, C J Stimson, et al.
Urologic Oncology|August 1, 2016
Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012)Meera R Chappidi, Max Kates, Michael H Johnson, et al.
Clinical Genitourinary Cancer|October 2, 2024
Impact of Baseline Renal Insufficiency on Piflufolastat F-18 Performance and Investigation of Changes in Renal Function Following Piflufolastat F-18 Administration: Results From the OSPREY TrialMeera R Chappidi, Amir Iravani, Nancy Stambler, et al.
Journal of Patient Safety|April 29, 2017
Cost-Benefit Analysis of a Support Program for Nursing StaffDane Moran, Albert W Wu, Cheryl Connors, et al.
World Journal of Urology|March 10, 2019
Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancerAaron Brant, Marcus Daniels, Meera R Chappidi, et al.
The Journal of Sexual Medicine|May 3, 2017
Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims DatabaseMeera R Chappidi, Max Kates, Nikolai A Sopko, et al.
BJU International|April 19, 2017
Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims databaseMeera R Chappidi, Max Kates, Jeffrey J Tosoian, et al.
JAMA|February 28, 2018
Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014Ruchika Goel, Meera R Chappidi, Eshan U Patel, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 21, 2017
Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder CancerNiv Milbar, Max Kates, Meera R Chappidi, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Urology|July 28, 2016
Quantifying Nonindex Hospital Readmissions and Care Fragmentation after Major Urological Oncology Surgeries in a Nationally Representative SampleMeera R Chappidi, Max Kates, C J Stimson, et al.
The Journal of Urology|August 23, 2016
Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of CareMeera R Chappidi, Max Kates, C J Stimson, et al.
Urologic Oncology|August 1, 2016
Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012)Meera R Chappidi, Max Kates, Michael H Johnson, et al.
Clinical Genitourinary Cancer|October 2, 2024
Impact of Baseline Renal Insufficiency on Piflufolastat F-18 Performance and Investigation of Changes in Renal Function Following Piflufolastat F-18 Administration: Results From the OSPREY TrialMeera R Chappidi, Amir Iravani, Nancy Stambler, et al.
Journal of Patient Safety|April 29, 2017
Cost-Benefit Analysis of a Support Program for Nursing StaffDane Moran, Albert W Wu, Cheryl Connors, et al.
World Journal of Urology|March 10, 2019
Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancerAaron Brant, Marcus Daniels, Meera R Chappidi, et al.
The Journal of Sexual Medicine|May 3, 2017
Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims DatabaseMeera R Chappidi, Max Kates, Nikolai A Sopko, et al.
BJU International|April 19, 2017
Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims databaseMeera R Chappidi, Max Kates, Jeffrey J Tosoian, et al.
JAMA|February 28, 2018
Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014Ruchika Goel, Meera R Chappidi, Eshan U Patel, et al.
Bladder Cancer (Amsterdam, Netherlands)|November 21, 2017
Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder CancerNiv Milbar, Max Kates, Meera R Chappidi, et al.
Pageof 4